Trimeric SARS-CoV-2 Spike proteins produced from CHO-cells in bioreactors are high-quality antigens
P. Pino, J. Kint, D. Kiseljak, V. Agnolon, G. Corradin, A. V. KAJAVA, P. Rovero, R. Dijkman, G. d. Hartog, J. S. McLellan, P. Byrne, M. J. Wurm, F. M. Wurm
This paper describes a scalable method to produce high-quality trimeric SARS-CoV-2 Spike proteins for vaccines and diagnostics.
bioRxiv · Nov 15, 2020Cell Biology